Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Second in a blog series by Cancer Research UK Oxford Centre for Blood Cancer Awareness Month

Radiologist treating cancer patient with radiotherapy © CRUK Assets Hub

Radiotherapy has been used as a treatment for cancer since the early 1900s. It’s an effective treatment for lymphomas, and relatively modest doses of radiation can kill lymphoma cells.

Alongside chemotherapy, radiotherapy continues to be a standard treatment option for many cancer types but, like most cancer treatments, it comes with its own risks and potential side effects.

Hodgkin lymphoma can appear in many areas, as the lymphatic system spans the whole body. Mantle radiotherapy was originally a standard treatment for Hodgkin lymphoma, and delivered the radiation treatment to a large area of the neck, chest and upper body. However, it has since become much less frequently used, as it has been shown to cause other forms of cancer, strokes and heart disease in patients 10+ years after treatment was finished.

Read the full blog on the Cancer Research UK Oxford Centre website

Similar stories

Just over half of British Indians would take COVID vaccine

Coronavirus COVID-19 General Research

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

General Innovation Research

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental mental health worsens under new national COVID-19 restrictions

Coronavirus COVID-19 General Research

Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.

£100 million donation from Ineos to create new institute to fight antimicrobial resistance

Awards and Appointments General Innovation

A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.